Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-2-23
pubmed:abstractText
The purpose of this study is to investigate the prognostic role of insulin-like growth factor receptor 1 (IGF1R) expression in surgically resected non-small-cell lung cancer (NSCLC). Patient characteristics and methods: This retrospective study was conducted in 369 stage I-II-IIIA, surgically resected, NSCLC patients. Patients exposed to anti-epidermal growth factor receptor (EGFR) agents were excluded. IGF1R expression was evaluated by immunohistochemistry in tissue microarray sections.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1569-8041
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
562-7
pubmed:meshHeading
pubmed-meshheading:19767315-Adenocarcinoma, pubmed-meshheading:19767315-Adenocarcinoma, Bronchiolo-Alveolar, pubmed-meshheading:19767315-Adult, pubmed-meshheading:19767315-Aged, pubmed-meshheading:19767315-Aged, 80 and over, pubmed-meshheading:19767315-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:19767315-Carcinoma, Squamous Cell, pubmed-meshheading:19767315-Cohort Studies, pubmed-meshheading:19767315-Female, pubmed-meshheading:19767315-Humans, pubmed-meshheading:19767315-Immunoenzyme Techniques, pubmed-meshheading:19767315-Lung Neoplasms, pubmed-meshheading:19767315-Male, pubmed-meshheading:19767315-Middle Aged, pubmed-meshheading:19767315-Neoplasm Staging, pubmed-meshheading:19767315-Receptor, IGF Type 1, pubmed-meshheading:19767315-Retrospective Studies, pubmed-meshheading:19767315-Survival Rate, pubmed-meshheading:19767315-Tissue Array Analysis, pubmed-meshheading:19767315-Treatment Outcome
pubmed:year
2010
pubmed:articleTitle
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.
pubmed:affiliation
Department of Oncology-Hematology, Istituto Clinico Humanitas Istituto di Ricerca a Carattere Scientifico (IRCCS), Rozzano. federico.cappuzzo@humanitas.it
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't